93 related articles for article (PubMed ID: 9628610)
1. Serum levels of total and free prostate specific antigen in men on hemodialysis.
Sasagawa I; Kubota Y; Hayami S; Adachi M; Nakada T; Miura H; Imai K
J Urol; 1998 Jul; 160(1):83-5. PubMed ID: 9628610
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of prostate specific antigen in men on hemodialysis.
Wolff JM; Ting O; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):5191-3. PubMed ID: 11326693
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T
Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
[TBL] [Abstract][Full Text] [Related]
4. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
[TBL] [Abstract][Full Text] [Related]
5. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
Passadakis P; Ersoy F; Tam P; Memmos D; Siamopoulos K; Ozener C; Akçiçek F; Camsari T; Ates K; Ataman R; Vlachojannis J; Dombros N; Utas C; Akpolat T; Bozfakioglu S; Wu GG; Karayaylali I; Arinsoy T; Stathakis C; Yavuz M; Tsakiris D; Dimitriades A; Yilmaz ME; Gültekin M; Karayalçin B; Challa A; Polat N; Oreopoulos DG
Adv Perit Dial; 2004; 20():203-8. PubMed ID: 15384827
[TBL] [Abstract][Full Text] [Related]
7. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men.
Ayatollahi H; Darabi Mahboub MR; Mohammadian N; Parizadeh MR; Kianoosh T; Khabbaz Khoob M; Kamalian F
Urol J; 2007; 4(4):238-41. PubMed ID: 18270950
[TBL] [Abstract][Full Text] [Related]
8. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
Irani J; Salomon L; Soulié M; Zlotta A; de la Taille A; Doré B; Millet C
Urology; 2005 Mar; 65(3):533-7. PubMed ID: 15780371
[TBL] [Abstract][Full Text] [Related]
9. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
[TBL] [Abstract][Full Text] [Related]
10. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
[TBL] [Abstract][Full Text] [Related]
11. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
12. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
13. Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers.
Ornstein DK; Smith DS; Rao GS; Basler JW; Ratliff TL; Catalona WJ
J Urol; 1997 Jun; 157(6):2179-82. PubMed ID: 9146610
[TBL] [Abstract][Full Text] [Related]
14. Effects of renal transplantation on serum-free and total PSA levels.
Kamali K; Zargar MA
Transplant Proc; 2007 May; 39(4):1027-8. PubMed ID: 17524882
[TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of free PSA/total PSA ratio in the early diagnosis of prostatic cancer].
Laguna Pes MP; Guinda Sevillano C; Zazo Romojaro A; Domínguez J; García Luzón A; Borrego Hernando J; Gimeno Collado A
Arch Esp Urol; 2000 May; 53(4):333-41. PubMed ID: 10900763
[TBL] [Abstract][Full Text] [Related]
16. Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study.
Wada Y; Nakanishi J; Takahashi W; Kai N; Nakayama Y; Yamashita Y; Honda J; Ueda S
BJU Int; 2006 Oct; 98(4):794-7. PubMed ID: 16978274
[TBL] [Abstract][Full Text] [Related]
17. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
Brawer MK; Cheli CD; Neaman IE; Goldblatt J; Smith C; Schwartz MK; Bruzek DJ; Morris DL; Sokoll LJ; Chan DW; Yeung KK; Partin AW; Allard WJ
J Urol; 2000 May; 163(5):1476-80. PubMed ID: 10751861
[TBL] [Abstract][Full Text] [Related]
18. Assay standardization bias: different prostate cancer detection rates and clinical outcomes resulting from different assays for free and total prostate-specific antigen.
Sotelo RJ; Mora KE; Pérez LH; Novoa J; Carmona O; De Andrade R; Borges RE; Parada D; Loeb S; Catalona WJ
Urology; 2007 Jun; 69(6):1143-6. PubMed ID: 17572203
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
[TBL] [Abstract][Full Text] [Related]
20. Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL.
Kravchick S; Peled R; Dorfman D; Agulansky L; Ben-Dor D; Cytron S
Urology; 2005 Sep; 66(3):542-6. PubMed ID: 16140074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
